New Viz.ai Study Demonstrates Reduced Mortality Rates in Patients with Pulmonary Embolism

This post was originally published on this site

Share this story

SAN FRANCISCO–(BUSINESS WIRE)– #ai–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced clinical data validating the impact of the Viz PE Solution in the management and outcomes of patients with pulmonary embolism (PE). The data was presented during the 2024 AVF (American Venous Forum) by Jacob Shapiro, M.D., vascular surgeon at TriHealth in Cincinnati, OH. The real-world study, “Shorter Time to Assessment and Anticoagulation with Decreased Mortalit

Comments are closed.